| P50 | author | Ricardo Riguera | Q42759891 |
| | Ramón Soto-Otero | Q55979160 |
| | Estefanía Méndez-Álvarez | Q58417120 |
| | Inés Sánchez-Sellero | Q59390493 |
| P2093 | author name string | M López-Rivadulla Lamas | |
| | E Quiñoá-Cabana | |
| P2860 | cites work | Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis | Q22242250 |
| | Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 |
| | Smoking, smoking cessation, and major depression | Q28296708 |
| | Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q33641852 |
| | Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine | Q33917363 |
| | Brain monoamine oxidase A inhibition in cigarette smokers | Q34063791 |
| | Irreversible inhibition of monoamine oxidase by some components of cigarette smoke | Q34691302 |
| | Inhibition of monoamine oxidase A by beta-carboline derivatives | Q34737351 |
| | Cyanide intoxication and its mechanism of antagonism | Q40212462 |
| | Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? | Q40546558 |
| | Tetrahydronorharmane (tetrahydro-beta-carboline), a physiologically occurring compound of indole metabolism | Q41044989 |
| | Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a beta-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+). | Q41282900 |
| | Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis | Q41523182 |
| | Gas chromatographic/mass spectrometric evidence for the identification of 1,2,3,4-tetrahydro-β-carboline as an invivo constituent of rat brain | Q41667935 |
| | Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity | Q44288510 |
| | Concentrations of tryptoline and methtryptoline in rat brain | Q44473048 |
| | Tetrahydro-beta-carbolines: specific inhibitors of type A monoamine oxidase in rat brain | Q48294980 |
| | Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium | Q48349404 |
| | Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes | Q48487617 |
| | Smoking and Parkinson's disease: a case-control study in Germany. | Q50953639 |
| | Dopamine Neurotoxicity: Inhibition of Mitochondrial Respiration | Q56226686 |
| | Interaction of 1,2,3,4-Tetrahydroisoquinoline with Some Components of Cigarette Smoke: Potential Implications for Parkinson's Disease | Q57517831 |
| | A retrospective study of smoking in Parkinson's disease. | Q67215966 |
| | Inhibition of mitochondrial succinate oxidation—Similarities and differences between N-methylated β-carbolines and MPP+ | Q67487733 |
| | Interaction of biogenic amines with components of cigarette smoke. Formation of cyanomethylamine derivatives | Q67947033 |
| | Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP | Q68834136 |
| | Does an endogenous methylpyridinium analogue cause Parkinson's disease? | Q69874640 |
| | Biogenic amine adducts, monoamine oxidase inhibitors, and smoking | Q69910905 |
| | Identification and quantification of 1,2,3,4-tetrahydro-beta-carboline, 2-methyl-1,2,3,4-tetrahydro-beta-carboline, and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline as in vivo constituents of rat brain and adrenal gland | Q70719535 |
| | The influence of brain acetaldehyde on oxidative status, dopamine metabolism and visual discrimination task | Q71950418 |
| | Differential cytotoxicities of N-methyl-beta-carbolinium analogues of MPP+ in PC12 cells: insights into potential neurotoxicants in Parkinson's disease | Q72304336 |
| | Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke | Q73292750 |
| | beta-Carbolines and Tetrahydroisoquinolines: Detection and Function in Mammals | Q79567495 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 155-162 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease | |
| P478 | volume | 802 | |